I
IX Biopharma Ltd
SGX:42C
IX Biopharma Ltd
SGX:42C
Price:
0.2
SGD
-2.44%
Market Closed
Market Cap:
S$191.9m
Income Statement
Earnings Waterfall
IX Biopharma Ltd
IX Biopharma Ltd
Income Statement
IX Biopharma Ltd
IX Biopharma Ltd
Currency: SGD
| Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
6
N/A
|
6
0%
|
6
+2%
|
6
+7%
|
6
+1%
|
7
+3%
|
3
-49%
|
2
-42%
|
0
-87%
|
(1)
N/A
|
0
N/A
|
1
+66%
|
1
+10%
|
1
+3%
|
1
+27%
|
1
+12%
|
2
+54%
|
2
+15%
|
14
+708%
|
14
+2%
|
4
-74%
|
6
+58%
|
6
+2%
|
6
-2%
|
7
+17%
|
8
+11%
|
7
-7%
|
|
| Gross Profit | ||||||||||||||||||||||||||||
| Cost of Revenue |
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(2)
|
(1)
|
(0)
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
(6)
|
(5)
|
|
| Gross Profit |
2
N/A
|
2
-7%
|
2
-1%
|
2
+32%
|
2
+8%
|
2
+1%
|
1
-45%
|
1
-46%
|
(0)
N/A
|
(1)
-237%
|
(0)
+50%
|
(1)
-31%
|
(1)
+3%
|
(1)
-25%
|
(1)
-54%
|
(1)
+42%
|
(0)
+41%
|
(0)
-9%
|
12
N/A
|
12
+3%
|
1
-91%
|
2
+120%
|
2
-13%
|
1
-48%
|
1
+23%
|
2
+59%
|
2
-1%
|
|
| Operating Income | ||||||||||||||||||||||||||||
| Operating Expenses |
(8)
|
(8)
|
(6)
|
(6)
|
(11)
|
(12)
|
(14)
|
(14)
|
(14)
|
(14)
|
(15)
|
(13)
|
(11)
|
(12)
|
(14)
|
(10)
|
(7)
|
(9)
|
(12)
|
(11)
|
(10)
|
(11)
|
(9)
|
(8)
|
(8)
|
(8)
|
(8)
|
|
| Selling, General & Administrative |
(7)
|
(6)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(8)
|
(8)
|
(8)
|
(8)
|
(10)
|
(9)
|
(9)
|
(8)
|
(10)
|
(9)
|
(9)
|
(9)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
|
| Research & Development |
(6)
|
(6)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(8)
|
(8)
|
(7)
|
(6)
|
(4)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
|
| Other Operating Expenses |
4
|
4
|
5
|
6
|
2
|
2
|
0
|
(1)
|
2
|
0
|
0
|
1
|
1
|
(1)
|
(0)
|
1
|
4
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Operating Income |
(7)
N/A
|
(6)
+10%
|
(4)
+29%
|
(4)
+11%
|
(9)
-123%
|
(10)
-15%
|
(13)
-28%
|
(14)
-10%
|
(14)
-3%
|
(15)
-7%
|
(15)
0%
|
(14)
+9%
|
(12)
+17%
|
(13)
-13%
|
(15)
-16%
|
(11)
+29%
|
(7)
+32%
|
(10)
-34%
|
0
N/A
|
1
+274%
|
(9)
N/A
|
(8)
+10%
|
(7)
+22%
|
(7)
-6%
|
(7)
-2%
|
(6)
+15%
|
(6)
+7%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||
| Interest Income Expense |
(1)
|
(0)
|
(0)
|
(0)
|
1
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(2)
|
(0)
|
(0)
|
0
|
(0)
|
2
|
(2)
|
(5)
|
(6)
|
(1)
|
(2)
|
(3)
|
(3)
|
(4)
|
(0)
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(8)
N/A
|
(6)
+21%
|
(4)
+28%
|
(4)
+10%
|
(8)
-89%
|
(10)
-32%
|
(13)
-27%
|
(14)
-9%
|
(15)
-10%
|
(15)
-1%
|
(16)
-1%
|
(14)
+8%
|
(13)
+7%
|
(13)
+0%
|
(15)
-16%
|
(10)
+32%
|
(8)
+28%
|
(8)
-9%
|
(1)
+85%
|
(4)
-231%
|
(16)
-280%
|
(10)
+38%
|
(8)
+14%
|
(10)
-19%
|
(10)
-3%
|
(10)
+1%
|
(6)
+41%
|
|
| Net Income | ||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
(1)
|
(1)
|
1
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(8)
|
(6)
|
(4)
|
(4)
|
(7)
|
(10)
|
(13)
|
(14)
|
(15)
|
(15)
|
(16)
|
(14)
|
(13)
|
(13)
|
(15)
|
(10)
|
(8)
|
(8)
|
(2)
|
(5)
|
(16)
|
(10)
|
(10)
|
(11)
|
(10)
|
(10)
|
(6)
|
|
| Net Income (Common) |
(8)
N/A
|
(6)
+21%
|
(4)
+28%
|
(4)
+9%
|
(7)
-87%
|
(10)
-33%
|
(12)
-26%
|
(14)
-11%
|
(15)
-10%
|
(15)
0%
|
(16)
-2%
|
(4)
+77%
|
(3)
+17%
|
(3)
-3%
|
(5)
-70%
|
(10)
-100%
|
(8)
+28%
|
(8)
-9%
|
(2)
+79%
|
(5)
-161%
|
(16)
-239%
|
(10)
+38%
|
(10)
+0%
|
(11)
-12%
|
(10)
+10%
|
(10)
-4%
|
(6)
+41%
|
|
| EPS (Diluted) |
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
0
N/A
|
-0.01
N/A
|
0
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.02
N/A
|
-0.04
-100%
|
-0.03
+25%
|
-0.03
N/A
|
-0.02
+33%
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
0
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
